SI1699489T1 - Farmacevtski sestavek z zaviralcem natrijevega kanaläśka in selektivni inhibitor ponovnega privzema serotonina - Google Patents
Farmacevtski sestavek z zaviralcem natrijevega kanaläśka in selektivni inhibitor ponovnega privzema serotoninaInfo
- Publication number
- SI1699489T1 SI1699489T1 SI200432028T SI200432028T SI1699489T1 SI 1699489 T1 SI1699489 T1 SI 1699489T1 SI 200432028 T SI200432028 T SI 200432028T SI 200432028 T SI200432028 T SI 200432028T SI 1699489 T1 SI1699489 T1 SI 1699489T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pharmaceutical composition
- sodium channel
- channel blocker
- selective serotonin
- uptake inhibitor
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
- 229940125794 sodium channel blocker Drugs 0.000 title 1
- 239000003195 sodium channel blocking agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0304095A HU230403B1 (hu) | 2003-12-19 | 2003-12-19 | Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény |
| PCT/HU2004/000123 WO2005058363A2 (en) | 2003-12-19 | 2004-12-18 | Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor |
| EP04806280A EP1699489B1 (en) | 2003-12-19 | 2004-12-18 | Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1699489T1 true SI1699489T1 (sl) | 2013-06-28 |
Family
ID=89981864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200432028T SI1699489T1 (sl) | 2003-12-19 | 2004-12-18 | Farmacevtski sestavek z zaviralcem natrijevega kanaläśka in selektivni inhibitor ponovnega privzema serotonina |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8048882B2 (sl) |
| EP (1) | EP1699489B1 (sl) |
| KR (1) | KR101177587B1 (sl) |
| CN (2) | CN103202845B (sl) |
| AU (1) | AU2004298911B2 (sl) |
| CA (1) | CA2556342A1 (sl) |
| CY (1) | CY1113977T1 (sl) |
| DK (1) | DK1699489T3 (sl) |
| EA (1) | EA013812B1 (sl) |
| ES (1) | ES2403181T3 (sl) |
| HR (1) | HRP20130241T1 (sl) |
| HU (1) | HU230403B1 (sl) |
| NZ (1) | NZ548514A (sl) |
| PL (1) | PL1699489T3 (sl) |
| PT (1) | PT1699489E (sl) |
| SI (1) | SI1699489T1 (sl) |
| WO (1) | WO2005058363A2 (sl) |
| ZA (1) | ZA200605791B (sl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| GB0613836D0 (en) * | 2006-07-13 | 2006-08-23 | Univ Greenwich | New medical use of triazine derivatives |
| CN104523593A (zh) * | 2014-12-25 | 2015-04-22 | 李健 | 一种抗皮肤瘙痒的外用喷雾剂 |
| KR101856589B1 (ko) | 2015-07-30 | 2018-05-10 | (주)에이엔티랩스 | 라모트리진의 피부성 약물 부작용 예측 방법 |
| HUP1900358A1 (hu) | 2019-10-12 | 2021-04-28 | Meditop Gyogyszeripari Kft | Lamotrigin és szertralin hatóanyag tartalmú gyógyszerkészítmények, ezek elõállítása és alkalmazása |
| WO2021146425A1 (en) * | 2020-01-14 | 2021-07-22 | Neurana Pharmaceuticals, Inc. | Methods of treating acute muscle spasms |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4614499A (en) * | 1985-04-29 | 1986-09-30 | Universite Laval | Simulator for use as a neurosurgical aid in determining potential paths for the implantation of probes through the human body |
| US5735817A (en) * | 1995-05-19 | 1998-04-07 | Shantha; T. R. | Apparatus for transsphenoidal stimulation of the pituitary gland and adjoining brain structures |
| US6673832B1 (en) * | 1998-05-04 | 2004-01-06 | Gudarz Davar | Methods for identifying compounds for treating pain |
| US20020151543A1 (en) * | 1998-05-28 | 2002-10-17 | Sepracor Inc. | Compositions and methods employing R (-) fluoxetine and other active ingredients |
| JP2002537247A (ja) * | 1999-02-18 | 2002-11-05 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 神経障害性疼痛の治療で用いるためのアロイルアミノアシルピロール |
| US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
-
2003
- 2003-12-19 HU HU0304095A patent/HU230403B1/hu not_active IP Right Cessation
-
2004
- 2004-12-18 AU AU2004298911A patent/AU2004298911B2/en not_active Ceased
- 2004-12-18 WO PCT/HU2004/000123 patent/WO2005058363A2/en not_active Application Discontinuation
- 2004-12-18 NZ NZ548514A patent/NZ548514A/en unknown
- 2004-12-18 DK DK04806280.6T patent/DK1699489T3/da active
- 2004-12-18 PL PL04806280T patent/PL1699489T3/pl unknown
- 2004-12-18 US US10/584,661 patent/US8048882B2/en not_active Expired - Fee Related
- 2004-12-18 CN CN201310073166.1A patent/CN103202845B/zh not_active Expired - Fee Related
- 2004-12-18 PT PT48062806T patent/PT1699489E/pt unknown
- 2004-12-18 CA CA002556342A patent/CA2556342A1/en not_active Abandoned
- 2004-12-18 KR KR1020067013930A patent/KR101177587B1/ko not_active IP Right Cessation
- 2004-12-18 EP EP04806280A patent/EP1699489B1/en active Active
- 2004-12-18 SI SI200432028T patent/SI1699489T1/sl unknown
- 2004-12-18 CN CNA2004800418303A patent/CN1917864A/zh active Pending
- 2004-12-18 ES ES04806280T patent/ES2403181T3/es active Active
- 2004-12-18 EA EA200601181A patent/EA013812B1/ru not_active IP Right Cessation
-
2006
- 2006-07-13 ZA ZA200605791A patent/ZA200605791B/en unknown
-
2013
- 2013-03-20 HR HRP20130241TT patent/HRP20130241T1/hr unknown
- 2013-05-02 CY CY20131100364T patent/CY1113977T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU0304095D0 (en) | 2004-03-29 |
| CY1113977T1 (el) | 2016-07-27 |
| AU2004298911A1 (en) | 2005-06-30 |
| CN103202845A (zh) | 2013-07-17 |
| CN1917864A (zh) | 2007-02-21 |
| CN103202845B (zh) | 2014-09-17 |
| DK1699489T3 (da) | 2013-05-06 |
| KR20070007040A (ko) | 2007-01-12 |
| ZA200605791B (en) | 2007-05-30 |
| EA200601181A1 (ru) | 2006-12-29 |
| HRP20130241T1 (hr) | 2013-04-30 |
| PT1699489E (pt) | 2013-04-18 |
| US8048882B2 (en) | 2011-11-01 |
| HUP0304095A2 (hu) | 2005-07-28 |
| US20070129370A1 (en) | 2007-06-07 |
| KR101177587B1 (ko) | 2012-08-27 |
| CA2556342A1 (en) | 2005-06-30 |
| EP1699489A2 (en) | 2006-09-13 |
| WO2005058363A3 (en) | 2006-07-20 |
| NZ548514A (en) | 2010-04-30 |
| WO2005058363A2 (en) | 2005-06-30 |
| HU230403B1 (hu) | 2016-04-28 |
| EP1699489B1 (en) | 2013-02-13 |
| EA013812B1 (ru) | 2010-08-30 |
| PL1699489T3 (pl) | 2013-07-31 |
| AU2004298911B2 (en) | 2010-07-15 |
| ES2403181T3 (es) | 2013-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL175615A0 (en) | Pharmaceutical compositions and kits containing a cholinesterase inhibitor and an antidepressant | |
| EP1633362A4 (en) | COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITION OF PARP | |
| HK1093975A1 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
| IL164352A (en) | A tweak antagonist drug to treat tweak-related conditions | |
| IL175305A0 (en) | Compositions and dosage forms for enhanced absorption of metformin | |
| AU2003291103A8 (en) | Pharmaceutical composition | |
| GB2394894B (en) | New use for pharmaceutical composition | |
| IL178366A0 (en) | Pharmaceutical compositions containing a calcium channel blocker and thiamine | |
| AU2003248122A8 (en) | Sodium channel inhibitor | |
| IS8287A (is) | Lyfjablanda sem felur í sér levóþýroxínnatríum | |
| HU0301154D0 (en) | Pharmaceutical composition | |
| AU2003250372A8 (en) | Pharmaceutical composition | |
| GB0307866D0 (en) | Pharmaceutical composition | |
| EP1699458A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB0329232D0 (en) | Pharmaceutical composition | |
| GB0317663D0 (en) | Pharmaceutical composition | |
| HK1093896A1 (en) | Medicinal composition | |
| HRP20030618A2 (en) | Pharmaceutical compositions having antibiotic effect | |
| PL1699489T3 (pl) | Kompozycja farmaceutyczna blokera kanału sodowego i selektywnego inhibitora wychwytu serotoniny | |
| GB0300885D0 (en) | Pharmaceutical composition | |
| HK1081451A1 (en) | Medicinal composition | |
| GB0306933D0 (en) | Pharmaceutical composition | |
| PL377147A1 (pl) | Doustna kompozycja | |
| HK1062274A1 (en) | Medicinal composition | |
| GB0307862D0 (en) | Pharmaceutical composition |